Pharmafile

JANUARY 13, 2023

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known severe “adverse events of special interest” (AESIs) which appeared in post-vaccination studies. read more. read more.

Vaccines 78

Vaccines FDA Communication 78

European Pharmaceutical Review

DECEMBER 15, 2023

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. The post Positive results for mRNA vaccine in melanoma patients appeared first on European Pharmaceutical Review.

Vaccines 94

Vaccines Research Laboratories Immunization 94

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 97

pharmaphorum

JANUARY 15, 2021

Now, speaking to him as the first vaccines are deployed in the UK, he highlights the importance of GSK’s employees and culture to the future of the company post-COVID. He highlights GSK’s recently announced sustainability ambitions as an example of how the company is aiming to “do the right thing” for wider society.

Vaccines 105

Vaccines 105

The Guardian - Pharmaceutical Industry

MAY 11, 2024

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives Last week’s announcement that AstraZeneca would no longer market its Covid vaccine brings an end to one of the century’s most remarkable medical stories.

Vaccines 41

Vaccines 41

The Guardian - Pharmaceutical Industry

JANUARY 16, 2024

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive.

Vaccines 106

Vaccines 106

The Guardian - Pharmaceutical Industry

APRIL 7, 2023

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives ‘A silver lining’: how Covid ushered in a vaccines golden era Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said.

Vaccines 101

Vaccines 101

The Guardian - Pharmaceutical Industry

AUGUST 19, 2022

Unlike jabs, nasal vaccines target the respiratory tract, the body’s first line of defence against infection People who receive a Covid booster dose in the UK next month will be among the first in the world to receive Moderna’s dual-variant vaccine , which protects against two strains of the virus.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

OCTOBER 5, 2020

As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. There is going to be no vaccination of people under 18.

Vaccines 111

Vaccines 111

pharmaphorum

OCTOBER 8, 2021

This impact on individuals has then extended to broader society with the wider economic costs of mental illness in England estimated at £105.2 We all know that prevention is better than cure – and a strong example is widespread COVID-19 vaccination, which is proving to be one of the most effective tools in helping us return to everyday life.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 13, 2021

IO Biotech, an oncology specialist formed and backed by Denmark’s Novo Holdings, has raised €127 million ($155 million) to further develop its cancer vaccine technology that has boosted efficacy of PD-1 immunotherapy in early trials. The post IO Biotech raises $155m to develop breakthrough cancer vaccine appeared first on.

Vaccines 95

Vaccines Immunization Compounding 95

The Guardian - Pharmaceutical Industry

DECEMBER 12, 2023

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.

Vaccines 46

Vaccines Immunization 46

pharmaphorum

MARCH 16, 2021

The decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, amid fears that it could undermine the response to the pandemic in Europe. . It is a completely one-sided argument, statistically, that we need to be vaccinating,” he said. “I

Vaccines 98

Vaccines Adverse Reactions 98

pharmaphorum

OCTOBER 23, 2020

Is a century-old vaccine a ‘game-changer’ for COVID-19? Today, the notion of ‘data science’ has permeated almost every area of society. This is especially true in the search for effective therapies to fight COVID-19, and a vaccine. Understanding the link between COVID-19 and the BCG vaccine.

Vaccines 110

Vaccines Immunization Hospitals 110

STAT

MARCH 5, 2024

After 18 months of debate, the World Trade Organization failed to adopt a controversial proposal to waive intellectual property protection for Covid-19 diagnostics and treatments, ending a furious attempt by civil society groups to bolster global access to needed medical products. The failure was not a surprise.

Vaccines 114

Vaccines 114

The Guardian - Pharmaceutical Industry

OCTOBER 10, 2022

Scientists ditch plans to develop nasal spray version of Oxford/AstraZeneca vaccine in its current form Hopes of distributing the Oxford/AstraZeneca Covid vaccine as a nasal spray have been dealt a blow after researchers said it performed poorly in its first clinical trial. Continue reading.

Vaccines 70

Vaccines 70

pharmaphorum

OCTOBER 21, 2022

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. The emergence of COVID-19 meant that public awareness around vaccination and its importance in fighting the spread of infectious disease has increased rapidly.

Vaccines 98

Vaccines Immunization Compounding Pharmaceutical Companies 98

pharmaphorum

DECEMBER 1, 2020

GPs in the UK have been urged to encourage patients to self-care, in advance of the anticipated roll-out of COVID-19 vaccines and the extra workload this will create. The post UK patients urged to self-care ahead of vaccine roll-out appeared first on.

Vaccines 64

Vaccines 64

European Pharmaceutical Review

SEPTEMBER 1, 2023

At the end of August 2023, BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) had recommended its adapted Comirnaty mRNA-based vaccine for regulatory approval as preventive treatment against the COVID-19 Omicron XBB.1.5 subvariant. percent of the total mRNA therapy market by 2029.

Immunization 87

Immunization Vaccines 87

pharmaphorum

JANUARY 31, 2022

Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new clinical trial of its mRNA-based candidate DS-5670 that focuses on its use as a booster dose. The Japanese group says it hopes to complete clinical development of the vaccine and bring it to market in Japan before the end of the year.

Vaccines 96

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 96

pharmaphorum

MARCH 3, 2021

T-cell therapies for COVID-19 were discussed at the American Society of Haematology (ASH) conference late last year, where AlloVir provided proof-of-concept data for its off-the-shelf T cell therapy that specifically targets the virus. The post ISA plans trials of T-cell boosting COVID-19 therapy appeared first on.

Immunization 105

Immunization Vaccines Hospitals 105

European Pharmaceutical Review

APRIL 5, 2024

Study data was presented at the 2023 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting. Last week, Moderna shared promising data for its next-generation COVID-19 vaccine. As of the latest data cut off at the end of May 2023, over 15 person-years of the therapy were administered.

Vaccines 86

Vaccines 86

pharmaphorum

MARCH 15, 2022

The COVID-19 pandemic has radically disrupted traditional medical society conferences in a way that could scarcely have been imagined in 2019. The vast majority of societies were able to transition their planned physical events to virtual formats within remarkably short periods of time, and some delivered impressive attendee experiences.

Labelling 105

Labelling Vaccines Communication 105

STAT

JUNE 7, 2023

Now that the biggest meeting in cancer research — and, really, one of the biggest annual conferences for the pharmaceutical industry as a whole — has drawn to a close, what did we learn from the latest annual meeting of the American Society of Clinical Oncology,   STAT asks. Here

Vaccines 72

Vaccines Hospitals Patient Care 72

European Pharmaceutical Review

AUGUST 18, 2022

Merck (MSD outside of the US and Canada) has entered into a collaboration agreement with Orna Therapeutics to discover, develop and commercialise multiple programmes of engineered circular RNA (oRNA) therapies, including vaccines and therapeutics in the areas of infectious disease and oncology.

Vaccines 85

Vaccines Research Laboratories Packaging 85

European Pharmaceutical Review

OCTOBER 23, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s data were featured at the European Society for Medical Oncology (ESMO) 2023 Congress. coli vaccine The post ESMO 2023: Janssen reveals data for intravesical delivery system appeared first on European Pharmaceutical Review. Sanofi-Janssen collaboration to advance novel E.

Pharmaceutical Companies 92

Pharmaceutical Companies Pharmaceutical Companies Hospitals Vaccines 92

pharmaphorum

NOVEMBER 29, 2021

The UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of cases of the new Omicron variant of SARS-CoV-2 has reached double figures. The boosters will be offered in order of descending age groups, with priority given to the vaccination of older adults and those in a COVID-19 at-risk group.

Vaccines 64

Vaccines Immunization 64

pharmaphorum

APRIL 4, 2022

After children five and above began to receive the vaccine, doctors found that some kids had vaccine-associated myocarditis (inflammation of the heart muscles) or pericarditis (inflammation of the heart’s outer lining). Promisingly, 76% of the US population has received at least one dose of the COVID-19 vaccine, and 73.5%

Vaccines 111

Vaccines Hospitals Dosage Immunization 111

pharmaphorum

JULY 7, 2022

Read on to find out about reaching the gold standard of lung cancer screening, the promise of therapeutic cancer vaccines, why diversity is essential in oncology trials, and much more. Realising the promise of cancer vaccines. Immunotherapy: building the fourth pillar of cancer treatment. Read Deep Dive: Oncology in full.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Roots Analysis

FEBRUARY 26, 2024

In those days, such persons were considered as abominations and shunned from society. Today, the monster Big Foot could have easily be treated and allowed to remain as an acceptable member of society despite his condition. A number of chronic degenerative conditions, such as cancer, are also being addressed using vaccines.

Vaccines 52

Vaccines 52

pharmaphorum

NOVEMBER 12, 2020

In the hours after Pfizer’s momentous vaccine news emerged on Monday #pfizerproud popped up on my social media feeds again and again from the firm’s employees, both past and present. Think you need to build manufacturing of a vaccine before you know what’s working. Think that we will do things in parallel, not sequential.

Vaccines 87

Vaccines FDA 87

pharmaphorum

JANUARY 12, 2022

If you had been told that within a few months, you’d be living in the middle of the biggest pandemic since the 1918 global flu outbreak, but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would you have thought?

Vaccines 52

Vaccines 52

Omnicell

JANUARY 10, 2023

However, pharmacists will need the right medication management solution and support to meet the significant operational challenges of administering the COVID-19 vaccine while managing growing patient demands for an expanding array of medication therapies and other healthcare services.

Medication Dispensing 52

Medication Dispensing Vaccines 52

pharmaphorum

DECEMBER 16, 2020

But Torbett says that right from the start of the pandemic there was a recognition of the challenges society and the NHS faced, and an “extraordinary” desire from the industry to support the national effort in every way it conceivably could. “We’ve The road to a vaccine. That had a significant impact on companies.”.

Vaccines 122

Vaccines 122

The People's Pharmacy

JUNE 22, 2023

Infections Take Less Toll When Grandmothers Are on the Job: In their most recent analysis, these investigators utilized historical demographic data from a dozen different regions of Finland ( Proceedings of the Royal Society B , May 31, 2023). This effect was most notable for deaths due to smallpox, diarrhea or respiratory infections.

Vaccines 90

Vaccines 90

pharmaphorum

DECEMBER 22, 2021

Welfie , a COVID-19-focused platform that provides testing, symptom checks, vaccine status data, and case tracking for schools and other academic organisations. “We are at our best when all segments of society work together; we must work collaboratively to achieve the best solutions,” she added. .

Vaccines 122

Vaccines 122

pharmaphorum

JUNE 1, 2022

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further.

Vaccines 145

Vaccines Immunization Hospitals Packaging 145